Literature DB >> 20840585

Proteoglycans in health and disease: the multiple roles of syndecan shedding.

Tina Manon-Jensen1, Yoshifumi Itoh, John R Couchman.   

Abstract

Proteolytic processes in the extracellular matrix are a major influence on cell adhesion, migration, survival, differentiation and proliferation. The syndecan cell-surface proteoglycans are important mediators of cell spreading on extracellular matrix and respond to growth factors and other biologically active polypeptides. The ectodomain of each syndecan is constitutively shed from many cultured cells, but is accelerated in response to wound healing and diverse pathophysiological events. Ectodomain shedding is an important regulatory mechanism, because it rapidly changes surface receptor dynamics and generates soluble ectodomains that can function as paracrine or autocrine effectors, or competitive inhibitors. It is known that the family of syndecans can be shed by a variety of matrix proteinase, including many metzincins. Shedding is particularly active in proliferating and invasive cells, such as cancer cells, where cell-surface components are continually released. Here, recent research into the shedding of syndecans and its physiological relevance are assessed.
© 2010 The Authors Journal compilation © 2010 FEBS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20840585     DOI: 10.1111/j.1742-4658.2010.07798.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  126 in total

1.  Alveolar heparan sulfate shedding impedes recovery from bleomycin-induced lung injury.

Authors:  W B LaRivière; S Liao; S A McMurtry; K Oshima; X Han; F Zhang; S Yan; S M Haeger; M Ransom; J A Bastarache; R J Linhardt; E P Schmidt; Y Yang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-22       Impact factor: 5.464

Review 2.  Concise review: endothelial stem and progenitor cells and their habitats.

Authors:  Michael S Goligorsky; Petri Salven
Journal:  Stem Cells Transl Med       Date:  2013-06-12       Impact factor: 6.940

3.  Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome.

Authors:  Szilvia Szabo; Yi Xu; Roberto Romero; Tibor Fule; Katalin Karaszi; Gaurav Bhatti; Tibor Varkonyi; Ildiko Varkonyi; Tibor Krenacs; Zhong Dong; Adi L Tarca; Tinnakorn Chaiworapongsa; Sonia S Hassan; Zoltan Papp; Ilona Kovalszky; Nandor Gabor Than
Journal:  Virchows Arch       Date:  2013-06-27       Impact factor: 4.064

Review 4.  An introduction to proteoglycans and their localization.

Authors:  John R Couchman; Csilla A Pataki
Journal:  J Histochem Cytochem       Date:  2012-09-26       Impact factor: 2.479

Review 5.  Polyunsaturated fatty acid metabolism in prostate cancer.

Authors:  Isabelle M Berquin; Iris J Edwards; Steven J Kridel; Yong Q Chen
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

6.  Soluble Syndecan-1: Does This Biomarker Address a Seemingly Insoluble Problem in Inflammatory Bowel Disease?

Authors:  Angela M Patterson
Journal:  Dig Dis Sci       Date:  2015-04-25       Impact factor: 3.199

Review 7.  Fell-Muir Lecture: Syndecans: from peripheral coreceptors to mainstream regulators of cell behaviour.

Authors:  John R Couchman; Sandeep Gopal; Hooi Ching Lim; Steffen Nørgaard; Hinke A B Multhaupt
Journal:  Int J Exp Pathol       Date:  2014-12-26       Impact factor: 1.925

8.  A transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17 and promotes lung epithelial tumor cell migration and lung metastasis formation.

Authors:  Tobias Pasqualon; Jessica Pruessmeyer; Sarah Weidenfeld; Aaron Babendreyer; Esther Groth; Julian Schumacher; Nicole Schwarz; Bernd Denecke; Holger Jahr; Pascale Zimmermann; Daniela Dreymueller; Andreas Ludwig
Journal:  Cell Mol Life Sci       Date:  2015-04-26       Impact factor: 9.261

Review 9.  Mechanisms of heparanase inhibitors in cancer therapy.

Authors:  Benjamin Heyman; Yiping Yang
Journal:  Exp Hematol       Date:  2016-08-26       Impact factor: 3.084

10.  Syndecan-1 Shedding Inhibition to Protect Against Ischemic Acute Kidney Injury Through HGF Target Signaling Pathway.

Authors:  Zhihui Lu; Nana Song; Bo Shen; XiaLian Xu; Yi Fang; Yiqin Shi; Yichun Ning; Jiachang Hu; Yan Dai; Xiaoqiang Ding; Jianzhou Zou; Jie Teng
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.